Plasma 25 hydroxyvitamin D level and blood gene expression profiles: A cross-sectional study of the Norwegian Women and Cancer Post-genome Cohort

European Journal of Clinical Nutrition

Volumn 67, Issue 7, 2013, Pages 773-778

  Standahl Olsen, K ^a   Rylander, C ^a   Brustad, M ^a   Aksnes, L ^b,c   Lund, E ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

gene expression profiling; calcitriol; nutrigenomics; prevention; immune system; vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; CD14 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 14; THROMBOMODULIN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CELL FUNCTION; CLUSTER OF DIFFERENTIATION 14 GENE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENOME ANALYSIS; GUANINE NUCLEOTIDE EXCHANGE FACTOR VAV3 GENE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; MICROARRAY ANALYSIS; MITOGEN ACTIVATED PROTEIN 14 GENE; NORWEGIAN; NUTRIENT CONCENTRATION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PROKINETICIN 2 GENE; SIGNAL TRANSDUCTION; THROMBOMODULIN GENE; TOLL LIKE RECEPTOR 2 GENE; TUMOR NECROSIS FACTOR RECEPTOR GENE; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 8 GENE;

BODY MASS INDEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME, HUMAN; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASMS; NORWAY; NUTRITIONAL STATUS; QUESTIONNAIRES; SIGNAL TRANSDUCTION; TRANSCRIPTOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84880134953     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2013.53     Document Type: Article

References (38)

1. Ross AC, Taylor CL, Yaktine AL, Del Valle HB. (eds). Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine, National Academy Press: Washington, DC, USA, 2011.
2. Heaney RP. Serum 25-hydroxyvitamin D is a reliable indicator of vitamin D status. Am J Clin Nutr 2011; 94: 619-620.
3. Baeke F, van Etten E, Gysemans C, Overbergh L, Mathieu C. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol Aspects Med 2008; 29: 376-387.
4. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726-776.
5. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian diabetes, obesity and lifestyle study). Diabetes Care 2011; 34: 1133-1138.
6. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8: 685-698.
7. Maxmen A. Nutrition advice: the vitamin D-lemma. Nature 2011; 475: 23-25.
8. Heikkinen S, Väisänen S, Pehkonen P, Seuter S, Benes V, Carlberg C. Nuclear hormone 1a, 25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res 2011; 39: 9181-9193.
9. Pike JW, Meyer MB, Bishop KA. Regulation of target gene expression by the vitamin D receptor-an update on mechanisms. Rev Endocr Metab Disord 2011; 13: 45-55.
10. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1, 25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am 2010; 39: 255-269.
11. Dumeaux V, Olsen KS, Nuel G, Paulssen RH, Borresen-Dale AL, Lund E. Deciphering normal blood gene expression variation-the NOWAC postgenome study. PLoS Genet 2010; 6: e1000873.
12. Waaseth M, Olsen KS, Rylander C, Lund E, Dumeaux V. Sex hormones and gene expression signatures in peripheral blood from postmenopausal women-the NOWAC postgenome study. BMC Med Genomics 2011; 4: 29.
13. Rylander C, Dumeaux V, Olsen KS, Waaseth M, Sandanger TM, Lund E. Using blood gene signatures for assessing effects of exposure to perfluoroalkyl acids (PFAAs) in humans: the NOWAC postgenome study. Int J Mol Epidemiol Genet 2011; 2: 207-216.
14. Lund E, Dumeaux V, Braaten T, Hjartaker A, Engeset D, Skeie G et al. Cohort profile: the Norwegian Women and Cancer Study-NOWAC-Kvinner og kreft. Int J Epidemiol 2008; 37: 36-41. (Pubitemid 351228607)
15. Dumeaux V, Borresen-Dale A-L, Frantzen J-O, Kumle M, Kristensen V, Lund E. Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study. Breast Cancer Res 2008; 10: R13.
16. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002; 48: 1883-1890. (Pubitemid 35222745)
17. Aksnes L. Simultaneous determination of retinol, alpha-tocopherol, and 25-hydroxyvitamin D in human serum by high-performance liquid chromato-graphy. J Pediatr Gastroenterol Nutr 1994; 18: 339-343. (Pubitemid 24125847)
18. Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 2004; 20: 93-99. (Pubitemid 38088346)
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550. (Pubitemid 41528093)
20. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 1995; 57: 289-300.
21. Goeman JJ, Buhlmann P. Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 2007; 23: 980-987. (Pubitemid 47050585)
22. Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 2011; 106: S5-S78.
23. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporespon-siveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36: 361-370. (Pubitemid 43257459)
24. Tarroni P, Villa I, Mrak E, Zolezzi F, Mattioli M, Gattuso C et al. Microarray analysis of 1, 25(OH)(2) D(3) regulated gene expression in human primary osteoblasts. J Cell Biochem 2011; 113: 640-649.
25. Kovalenko P, Zhang Z, Cui M, Clinton S, Fleet J. 1, 25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1. BMC Genomics 2010; 11: 26.
26. Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ. 1alpha, 25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther 2007; 6: 1433-1439. (Pubitemid 46712007)
27. Ordóñez-Morán P, Larriba MJ, Pálmer HG, Valero RA, Barbáchano A, Duñach M et al. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J Cell Biol 2008; 183: 697-710.
28. Stuckey A, Fischer A, Miller D, Hillenmeyer S, Kim K, Ritz A et al. Integrated genomics of ovarian xenograft tumor progression and chemotherapy response. BMC Cancer 2011; 11: 308.
29. Baeke F, Korf H, Overbergh L, Verstuyf A, Thorrez L, Van Lommel L et al. The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol 2011; 186: 132-142.
30. Canales RD, Luo Y, Willey JC, Austermiller B, Barbacioru CC, Boysen C et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol 2006; 24: 1115-1122. (Pubitemid 44359723)
31. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile: 1, 25-Dihydrox-yvitamin D3 works as anti-inflammatory. Diab Res Clin Prac 2007; 77: 47-57. (Pubitemid 46590467)
32. Riek AE, Oh J, Bernal-Mizrachi C. Vitamin D regulates macrophage cholesterol metabolism in diabetes. J Steroid Biochem Mol Biol 2010; 121: 430-433.
33. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010; 20: 1352-1360.
34. Sun X, Morris KL, Zemel MB. Role of calcitriol and cortisol on human adipocyte proliferation and oxidative and inflammatory stress: a microarray study. J Nutrigenet Nutrigenomics 2008; 1: 30-48. (Pubitemid 350032089)
35. Costa J, Eijk P, van de Wiel M, ten Berge D, Schmitt F, Narvaez C et al. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knockdown. BMC Genomics 2009; 10: 499.
36. Lisse TS, Liu T, Irmler M, Beckers J, Chen H, Adams JS et al. Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling. FASEB J 2011; 25: 937-947.
37. Carlberg C, Seuter S. A genomic perspective on vitamin D signaling. Anticancer Res 2009; 29: 3485-3493.
38. Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1alpha, 25(OH)2vitamin D3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011; 25: 543-559.